What are you searching for?

Meet the Author

Tomi Shobande

Tomi is passionate about building relationships with clients and helping them attain their business goals and objectives. With a background in law, international development and human rights, she is keen on bringing about a positive difference around healthcare inequities and shaping health outcomes for all groups.

Tomi enjoys spending good quality time with friends and family. She also is passionate about travel and learning different cultures and histories along the way.

Articles by Tomi Shobande

Product Launch Tracker Header Image

06.06.2022 | Article

Product Launch Tracker

Discover which new drug approvals HCPs are talking about

By Paul Cranston and Tomi Shobande

19.05.2022 | Article

Product Launch Tracker: HCPs excited for BMS’ newly approved ‘Camzyos’

Discover which new drug approvals HCPs are talking about

By Paul Cranston and Tomi Shobande

13.05.2022 | Article

4 key considerations for healthcare market research

The healthcare industry witnessed a paradigm shift since the COVID-19 pandemic began...

By Tomi Shobande

12.04.2022 | Article

Product Launch Tracker: HCPs discuss approvals for several cancer treatments and a…

HCPs discuss approvals for several cancer treatments and a fourth dose of COVID-19 vaccines

By Paul Cranston and Tomi Shobande

11.03.2022 | Article

Product Launch Tracker: Approvals for Boehringer Ingelheim, Eli Lilly, and Novo Nordisk…

HCPs discuss approvals for Boehringer Ingelheim, Eli Lilly, and Novo Nordisk

By Paul Cranston and Tomi Shobande

09.02.2022 | Article

Product Launch Tracker: HCPs celebrate new treatments for metastatic melanoma and non-small…

HCPs also shared the news of approvals of treatments for NSCLC

By Paul Cranston and Tomi Shobande

10.01.2022 | Article

Product Launch Tracker: Pre-Christmas approvals drive HCPs conversations

Discover which new drug approvals dominated HCPs conversations pre-Christmas...

By Paul Cranston and Tomi Shobande

01.12.2021 | Article

Product Launch Tracker: HCPs welcome approvals for MSD’s Keytruda and Takeda’s Livtencity

Discover which new drug approvals HCPs are talking about

By Paul Cranston and Tomi Shobande